Lime Pharma ApS: Financial statements 2020
CVR: 36941901
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
Lime Pharma ApS (CVR 36941901) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 278,758 and a net result of DKK 187,387 compared with DKK 217,678 the year before. That is an increase of 27.9% compared with the year before. Equity in the 2020 report amounted to DKK -201,078.
- Gross Profit
- DKK 278,758
- Profit/Loss
- DKK 187,387
- Equity
- DKK -201,078
- Total Assets
- DKK 609,390
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | 279 t. | 187 t. | -201 t. | - |
| 2019 | - | 218 t. | 218 t. | -388 t. | - |
| 2018 | - | 333 t. | 278 t. | -606 t. | - |
| 2017 | - | 412 t. | 169 t. | -884 t. | - |
| 2016 | - | 291 t. | -114 t. | -1.1 mio. | - |
How creditworthy is Lime Pharma ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
Lime Pharma ApS has published its annual report for 2019. Gross profit came to DKK 217,918, and the net result was DKK 217,678.
About Lime Pharma ApS
Lime Pharma ApS is a Danish company of the type Anpartsselskab based in Gilleleje, founded in 2015. The company is registered under the industry Engroshandel med andre fødevarer. The management consists of Birgit Beenfeldt. The company is owned by Birgit Beenfeldt. The company has 2 employees (2018). In 2025, the company reported a gross profit of DKK 68,312 and a net result of DKK 23,844 compared with DKK 59,370 the year before. Equity in the 2025 report amounted to DKK -61,418.